BRIGHT MINDS BIOSCIENCES INC. Increase Decrease In Cash And Cash Equivalents
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Increase Decrease In Cash And Cash Equivalents of -CAD 1.04 million for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2024-12-31
| Period end | Increase Decrease In Cash And Cash Equivalents 4 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2024-09-30 | -1.04M CAD 20-F · filed 2024-12-31 | |
| 2023-09-30 | -4.83M CAD 20-F · filed 2024-12-31 | |
| 2022-09-30 | -8.39M CAD 20-F · filed 2024-12-31 | |
| 2021-09-30 | 18.74M CAD 20-F · filed 2023-12-29 | |
| 2020-09-30 | 719.94K CAD 20-F · filed 2022-12-29 | |
| 2019-09-30 | 79.99K CAD 20-F/A · filed 2022-01-18 |